Welcome to our dedicated page for Dynatronics news (Ticker: DYNT), a resource for investors and traders seeking the latest updates and insights on Dynatronics stock.
Dynatronics Corporation news has centered on the company's historical role as a manufacturer of athletic training, physical therapy, rehabilitation, pain management, and restorative medical products. Coverage has included quarterly financial results, demand trends in rehabilitation products, operating-cost and margin commentary, product-line additions such as Timber, Titan Premier, and Forged, and distribution to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals.
Recurring updates also cover Dynatronics' brand portfolio, including Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM, as well as board appointments, capital and credit-line disclosures, and the company's transition from Nasdaq trading to OTCQB quotation.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Dynatronics Corporation (NASDAQ:DYNT) reported its Q2 fiscal year 2023 results, showcasing total net sales of $10.9 million and a gross profit margin increase to 28.1% from 19.8% a year prior. Net loss improved to $0.8 million, down from $1.4 million, and current liabilities reduced by $1.0 million. The company reaffirmed its net sales guidance for fiscal year '23 at $45 million to $48 million, projecting a 5% improvement from the previous year. However, it deferred gross margin guidance due to inflationary pressures and other economic challenges.
Dynatronics Corporation (NASDAQ:DYNT) announced a 1-for-5 reverse stock split effective February 1, 2023, at 5:00 p.m. (ET) to comply with NASDAQ's minimum bid price requirement. As a result, outstanding shares will reduce from approximately 19.6 million to 3.9 million. The common stock will trade on a split-adjusted basis starting February 2, 2023. The reverse stock split will not affect the Series A and B preferred stock, though their conversion ratios will change. The company seeks to maintain compliance with NASDAQ's listing requirements, but no guarantees can be made regarding future compliance.
Dynatronics Corporation (NASDAQ:DYNT) announced its second-quarter financial results for fiscal year 2023, scheduled for release on February 9, 2023, before market open. Following the results, a conference call will take place at 8:00 AM ET, featuring management remarks, a slide presentation, and a Q&A session. Interested participants can access the call by dialing specific numbers provided in the release, and a replay will be available until February 16, 2023. The company manufactures products for athletic training, physical therapy, and rehabilitation, emphasizing its commitment to high-quality restorative solutions.
Dynatronics Corporation (NASDAQ:DYNT) reported its Q1 fiscal year 2023 results, revealing net sales of $12.1 million and a gross profit margin increase to 30.2% from 23.4% in Q4 FY22. The net loss improved to $0.5 million from $1.6 million. The company maintains a debt-free status for the 9th consecutive quarter. Guidance for FY23 net sales is set at $45 million to $48 million, a 5% increase from FY22. However, due to inflation, gross margin guidance is deferred as the company anticipates continued volatility from economic challenges.